Reporter Staff
| This email address is being protected from spambots. You need JavaScript enabled to view it.Unlock the power of effective email communication
Learn 5 steps to writing emails that work in this 30-minute session at 11 a.m. July 15. Register now.
UAB and Birmingham Promise: a partnership for the future
Annual performance evaluation cycle opens July 1
• Is your viral load suppressed/undetectable?
• Are you able to receive an infusion or injection?
• Are you generally healthy?
• Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a HIV treatment study looking at an investigational way to effectively clear the HIV virus in areas of the body that standard antiretroviral treatment is unable to reach. You will receive one of two potential intervention methods. One intervention method is a broadly neutralizing antibody that is given to control growth of the HIV virus and to increase the body’s immune system response. The second intervention method is an injection (IL-15 Superagonist) designed to awaken the immune system, activate any dormant HIV virus, and then kill the virus. The duration of this study is approximately 84-112 weeks pending on which intervention method you receive. There is compensation at each study visit for time and travel.
Contact: If interested, please email kspraggins@uabmc.edu or call 205-934-9346
3 chosen as UAB VIPs for second-quarter 2024
John Huffstutler, Nancy Parsons and Angel Simmons are the second-quarter 2024 honorees of the UAB Values in Action Program. Nominations for third-quarter 2024 honorees are open through July 11.